Frazier Life Sciences — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Quanta TherapeuticsMay 2023SEC filingmedium confidence
South San Francisco, US
Board seatMaria Fardis· per SEC Form D · $89.1M raise · filed Jun 2026
Lengo TherapeuticsApr 2023
BiotechMenlo Park, US
Daniel Estes, Ph.D.(President)Tracy Saxton, Ph.D.(Director)Helen Jenkins(Chief Executive Officer)Roger Ulrich, Ph.D.(Director)Steve Bailey(Vice President)Anna Chen(Treasurer and Secretary)
Radionetics Oncologyradioneticsoncology.comAug 2023
BiotechMenlo Park, US
Brett Ewald(Executive Officer)Andrew Schwab(Director)Umesh Gangadharmath(Executive Officer)Dan Estes(Executive Officer, Director)Istvan Molnar(Executive Officer)Yunfei Zhu(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.